Embryo implantation requires a healthy embryo and a receptive endometrium (inner lining of the uterus); endometrial receptivity acquisition involves considerable epithelial surface remodeling. Dystroglycan (DG), a large cell surface glycoprotein, consists of a-and b-subunits; b-DG anchors within the plasma membrane whereas a-DG attaches extracellularly to b-DG. The glycosylated central a-DG mediates adhesion, but it is obstructed by its large N terminus (a-DG-N); a-DG-N removal enables DG's adhesive function. We demonstrate here that full-length a-DG in the human endometrial epithelium is a barrier for embryo attachment and that removal of a-DG-N by proprotein convertase 5/6 (PC6; a protease critical for implantation) regulates receptivity. This was evidenced by: 1) a-DG contains a PC6-cleavage site near a-DG-N, and PC6 cleaves a peptide harboring such a site; 2) PC6 knockdown reduces a-DG-N removal from endometrial epithelial cell surface and blastocyst adhesion; 3) mutating the PC6-cleavage site prevents a-DG-N removal, causing cell surface retention of full-length a-DG and loss of adhesiveness; 4) a-DG-N is removed from endometrial tissue in vivo for receptivity and uterine fluid a-DG-N reflects tissue removal and receptivity. We thus identified a-DG-N removal as an important posttranslational control of endometrial receptivity and uterine fluid a-DG-N as a potential biomarker for receptivity in women.-Heng, S., Paule, S. G., Li, Y., Rombauts, L. J., Vollenhoven, B., Salamonsen, L. A., Nie, G. Posttranslational removal of a-dystroglycan N terminus by PC5/6 cleavage is important for uterine preparation for embryo implantation in women. FASEB J. 29, 4011-4022 (2015). www.fasebj.org
human endometrial stromal cells, a process that is also important for embryo implantation (13) . Endometrial PC6 is secreted into the uterine fluid of women, and PC6 levels detected in uterine lavage fluids correlate with receptivity (12) . These studies suggest an important regulatory role of PC6 in the establishment of endometrial receptivity for implantation.
Previous studies identified a number of PC6-regulated proteins in human endometrial decidual cells (7, 14, 15) . However, as the luminal epithelium is the first contact between the endometrium and a blastocyst for implantation, identifying molecules that are directly regulated by PC6 for endometrial epithelial receptivity is critically important. Our previous studies suggest that PC6 cleaves a key scaffolding protein EBP50 (2) , thereby regulating the interaction between the plasma membrane and the cytoskeleton to profoundly influence endometrial epithelial cell morphology and adhesiveness to embryo attachment. In the current study, we investigated the potential role of PC6 in regulating endometrial epithelial cell receptivity through posttranslational regulation of a large cell surface glycoprotein/adhesion molecule DG.
DG, encoded by the DAG1 gene (16) , was originally identified in skeletal muscle as a component of the dystrophin-glycoprotein complex (17, 18) . DG is known to be ubiquitously expressed and important for cell adhesion, acting as a linker between the extracellular matrix and the cytoskeleton. DG is initially synthesized as a precursor protein, which is then posttranslationally processed into 2 noncovalently associated a-and b-subunits (19) . The b-DG subunit is anchored within the plasma membrane, and a-DG is noncovalently associated extracellularly to b-DG. The a-DG has a well-defined "dumbbell" shape comprising one large globular domain at each end and one central mucinlike region in the middle (20) . The central mucinlike region of a-DG (amino acids 316-485) is heavily decorated with N-and O-linked glycans (21, 22) , and this region mediates cell adhesion; however, it is obstructed by its large N terminus (a-DG-N, amino acid 30-312). Proteolytic cleavage at amino acid 312 by a furinlike enzyme would remove a-DG-N (23, 24) , and unmask the central mucinlike region of a-DG to interact with extracellular matrix proteins such as laminin (25) . In development, a-DG binding to laminin is important for early embryonic formation of the basement membrane; mice null for DAG1 gene die at embryonic d 6.5 due to failure in forming Reichert's membrane (26) .
The b-DG subunit spans the plasma membrane and links a-DG to the cytoskeleton directly or indirectly, via cytoskeletal proteins such as dystrophin, utrophin, and ezrin depending on tissue types (27) (28) (29) (30) . The a-DG subunit binds to several extracellular molecules such as laminin, agrin, and perlecan depending on tissue types (31) (32) (33) ; however, these interactions require glycosylation of central a-DG (34) . Furthermore, the N-terminal domain of a-DG (a-DG-N) is essential for the production of a functional a-DG, because glycosyltransferases such as like-acetylglucosaminyltransferase (LARGE) interact with a-DG-N to recognize DG as a substrate to glycosylate the central a-DG, and glycosylation does not occur if a-DG-N is absent (35, 36) . However, after glycosylation, proteolytic removal of a-DG-N is required because it obstructs the central a-DG from binding to extracellular molecules (36) .
Previous studies in cancer cells suggest that a furinlike enzyme is responsible for a-DG-N removal (37) . However, the significance of such cleavage to remove a-DG-N in normal physiology is unknown. The present study investigated the importance of a-DG-N removal in human endometrial epithelial cells in preparation for embryo implantation. We have identified that the intact DG in endometrial epithelial cells acts as a barrier for embryo attachment, and that a-DG-N removal is required to establish endometrial receptivity. Furthermore, we have established that PC6, the only PC member that is important for embryo implantation, cleaves a-DG-N in human endometrial epithelial cells for receptivity. Our studies have also identified that the cleaved a-DG-N is a potential biomarker for endometrial receptivity.
MATERIALS AND METHODS
In vitro cleavage of a-DG peptides by PC6
A peptide representing a-DG amino acids 299-319 that encompasses the predicted PC6-cleavage site (ANKKPPLPKRVRR 312 ↓ QIHATPTP), and a mutant (Mut) counterpart in which the amino acids around 312 were replaced by alanines (ANKKPPL-PAA 312 AAAQIHATPT), were custom-synthesized (Mimotopes, Clayton, VIC, Australia). These peptides were incubated with 10 U of recombinant human PC6 (PhenoSwitch Biosciences, Inc., Sherbrooke, QC, Canada) in DMEM/F12 at 37°C for 24 h, and the cleavage products were analyzed by surface-enhanced laser desorption ionization (SELDI) mass spectrometry with the ProteinChip Reader series 4000 personal edition (Bio-Rad, Hercules, CA, USA).
Culture of human endometrial epithelial HEC-1A cells
A previously established HEC-1A cell line with 50% knockdown of PC6 by stable small interfering RNA (siRNA) transfection (2) (a generous gift from Professor Carlos Simón, University of Valencia, Valencia, Spain) was used to determine whether PC6 regulates a-DG-N cleavage. These cells were cultured in complete medium containing McCoy medium (Life Technologies, Carlsbad, CA, USA) supplemented with 10% (v/v) fetal calf serum (FCS) (Life Technologies) and 2% geneticin (G418; Sigma-Aldrich, St. Louis, MO, USA) at 37°C.
Establishment of Ishikawa cells stably expressing different forms of DG
Human endometrial epithelial Ishikawa cell line, which expresses steroid receptors and is widely used to study endometrial epithelial receptivity, was chosen to further examine the significance of DG cleavage. An expression construct of human DG open reading frame (ORF) with a C-terminal DDK tag was purchased from Origene (in True ORF vector, Rockville, MD, USA), and designated as the wild-type (WT) DG construct. The arginine at the PC6-cleavge site (R 312 ) was replaced with alanine to make the Mut DG construct, by site-direct mutagenesis (QuikChange II XL Site-Directed Mutagenesis Kit, Agilent Technologies, Santa Clara, CA, USA) with primers 59-cccaaacgcgtccgggcgcagatccatgctac-39 and 59-gtagcatggatctgcgcccggacgcgtttggg-39. The control plasmid was an empty pCMV6 vector from Origene. Ishikawa cells (a generous gift by Professor Masato Nishida of National Hospital Organization, Kasumigaura Medical Center, Ibaraki-ken, Japan)
were cultured overnight in 6-well plates in complete media containing modified Eagle's medium (MEM, Life Technologies) supplemented with 10% (v/v) FCS, washed with PBS (Life Technologies) and replenished with Opti-MEM medium (Life Technologies). A master mix of plasmid DNA and lipofectamine transfection reagent (Life Technologies) in a 1:3 ratio was prepared, added into the cells (5 mg DNA/well), and incubated at 37°C for 24 h. Cells were then changed into fresh Opti-MEM, cultured for another 24 h, and transferred into a 10 cm Petri dish containing complete medium and 2% Geneticin. After culturing for 5 d, cells were trypsinized, seeded very sparsely into 25 cm Petri dishes (about 20,000 cells), and cultured until individual colonies formed. These colonies were then trypsinized individually, transferred into 96-well plates, and cultured in medium with 2% geneticin. Colonies that grew well were further transferred sequentially to 48-, 24-, 12-, and 6-well plates at 80% confluency. The final colonies were confirmed by Western blot for the DDK-tag and different regions of DG.
Protein extraction and Western blot analysis
Cells (HEC-1A and Ishikawa) were lysed with 50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1% (v/v) Triton X-100, 1 mM EGTA, and 2 mM EDTA containing protease inhibitors (Calbiochem, Darmstadt, Germany), and proteins were collected following centrifugation (14,000 rpm for 10 min at 4°C). Serum-free conditioned medium from HEC-1A cells were concentrated using Vivaspin columns with a 3000 Da cutoff (Satorius Stedim Biotech, Goettingen, Germany). Undiluted serum-free medium from Ishikawa cells were used.
To prepare membrane proteins, HEC-1A cells were lysed in an ice cold lysis buffer (25 mM imidazole and 100 mM NaC1 pH 7.0 containing protease inhibitors), passed through a 27.5 gauge needle and syringe 7 times, and centrifuged (15,000 g for 5 min at 4°C). The supernatant was incubated with 100 mM Na 2 CO 3 on ice for 60 min (with vortex every 15 min) and centrifuged (100,000 g for 60 min) to collect the pellet.
Protein concentrations were determined by a Bradford assay (Bio-Rad), and standard Western blot (10% SDS-PAGE gel) was performed using primary antibodies for different regions of DG (all at 1 mg/ml; 4F7, mouse monoclonal; N14, C15, and N18, all goat polyclonal; Santa Cruz Biotechnology, Santa Cruz, CA, USA) with appropriate anti-horseradish peroxidase (HRP) secondary antibodies (Dako, North Sydney, NSW, Australia). As DG expression constructs contained a C-terminal DDK-tag, Ishikawa cell lysates were also analyzed with a mouse monoclonal DDK antibody (at 1 mg/ml, Origene). All blots were visualized by chemiluminescence (Thermo Scientific, Waltham, MA, USA). To confirm equal loading, blots were stripped and reprobed for b-actin HRP conjugate (antibody at 0.4 mg/ml, Cell Signaling, Danvers, MA, USA), or for Na + /K + -ATPase (for HEC-1A membrane proteins only, antibody at 1 mg/ml, Santa Cruz Biotechnology).
Immunofluorescence analysis of DG in cell lines
Cells were grown on chamber slides, fixed in 4% (w/v) paraformaldehyde, and blocked with bovine serum albumin. Cells were probed first with primary antibodies for b-DG (4F7 at 2 mg/ml) or a-DG-N (WH0001605M1, mouse monoclonal at 8 mg/ml, Sigma-Aldrich), then with a goat anti-mouse secondary antibody labeled with Alexa 488 (at 5 mg/ml, Invitrogen, Molecular Probes, Carlsbad, CA, USA). The nuclei were stained with TO-PRO-3-iodide (1:1000 dilution or at 1 mM; Invitrogen, Molecular Probes). Staining was visualized by confocal microscopy (Olympus Optical, Tokyo, Japan), and the staining intensity and pattern were compared among different cell types within the same cell line.
Immunohistochemical localization of DG subunits in the human endometrium
Ethical approval was obtained from the Human Ethics Committee at Monash Medical Centre (Melbourne, Australia), and all subjects provided informed consent. Endometrial biopsies from different phases of the menstrual cycle were obtained from women undergoing curettage after laparoscopic sterilization or assessment of tubal patency. Menstrual cycle stage was confirmed by routine histologic dating of the tissue. Biopsies were fixed in formalin and embedded in wax as previously described (38) . Sections of 5 mM were deparaffinized in histosol and rehydrated, and antigen was retrieved by microwaving (10 min in 0.01 M citrate buffer pH 6.0). Endogenous peroxidase was quenched with 3% H 2 O 2 in methanol for 10 min and nonspecific binding was blocked with preimmune serum. The sections were incubated for 1 h at 37°C with primary antibodies for b-DG (4F7 at 6 mg/ml), a-DG-C (C15 at 1 mg/ml), or a-DG-N (Ν15 at 3 mg/ml). Mouse or goat IgG (Dako) replaced the primary antibodies in the respective negative controls. Sections were washed and appropriate biotinylated secondary antibodies (Vector Laboratories, Burlingame, CA, USA) were applied for 30 min at room temperature. Signals were amplified with StreptABC/HRP (Dako) and visualized with diaminobenzidine (Dako). The relative intensity of immunostaining in epithelial cells was scored semiquantitatively by 2 independent observers (0 = no stain, 4 = maximal stain) and data were expressed as the mean intensities (6SEM).
Western blot analysis of DG in uterine fluid
Uterine lavage fluids (n = 16) were obtained from women with proven fertility during the proliferative (n = 8) and secretory (n = 8) phases of the menstrual cycle. To collect uterine lavage, 3 ml of sterile saline was gently infused transcervically through a fine flexible catheter into the uterine cavity, and the fluid was recovered by aspiration. Cell debris was removed by centrifugation (1000 rpm for 5 min) and aliquots were stored at 280°C. Lavage samples were analyzed by standard Western blot (10% SDS-PAGE gel) for a-DG-N, using antibody N18 at (1 mg/ml), an anti-goat alkaline phosphatase secondary antibody (1:50,000 dilution, Sigma-Aldrich), and a fluorescent substrate (GE Healthcare, Rydalmere, NSW, Australia). Signals were visualized by a Multi Gauge (FLA-5100; Fujifilm, Tokyo, Japan scanner. Relative protein levels were determined by densitometry analysis with ImageJ, version 1.47 (National Institutes of Health, Bethesda, MD, USA).
Analysis of Ishikawa cell adhesion to laminin and fibronectin
Adhesion to laminin was assessed using laminin-coated 96-well plates (Merck Millipore, Bayswater, VIC, Australia) according to the manufacturer's instructions. For fibronectin adhesion, 96-well plates were coated with 10 mg/ml fibronectin (Corning Life Sciences, Tewksbury, MA, USA; dissolved in sterile H 2 O to 1 mg/ml and diluted to the required concentration with MEM serum-free medium) for 1 h at room temperature, and washed with sterile H 2 O. Ishikawa cells suspended in serum-free MEM medium were added to the fibronectin-coated wells (10,000 cells/well) and incubated for 1 h at 37°C. Nonadhered cells were removed, the wells were gently washed twice with PBS + (containing Ca 2+ /Mg 2 ), and incubated with crystal violet (0.2% in 10% ethanol, 100 ml/well) for 5 min at room temperature without agitation. After removing the crystal violet, the wells were washed 3 times with PBS + to remove all the remaining stain, and incubated with a solubilization buffer (A 50/50 mixture of 0.1 M NaH 2 PO 4 and ethanol, pH 4.5; 100 ml/well) for 5 min under gentle agitation. The absorbance at 560 nm was measured on an Envision plate reader (PerkinElmer, Waltham, MA, USA).
Spheroid attachment assay

Formation of trophoblast BeWo spheroids
BeWo spheroids were made using methylcellulose as previously described (39) . In brief, methylcellulose powder (Sigma-Aldrich) was dissolved to 10 mg/ml in DMEM (Life Technologies) by microwaving on low heat for 2-5 min (or until the powder is dissolved). The solution was stirred with a magnetic stirrer for 90 min at room temperature followed by overnight at 4°C, and centrifuged at 2300 g for 90 min at room temperature. The clear viscous supernatant was stored at 4°C for future use. In parallel, human trophoblast BeWo cells (American Type Culture Collection, Manassas, VA, USA) grown in DMEM/F-12 medium (Life Technologies) containing 10% (v/v) FCS, were trypsinized and resuspended at 2 3 10 5 cells/ml. The methylcellulose stock was diluted in BeWo cell complete medium (20% of final volume), added to the cell suspension and mixed gently but thoroughly; 150 ml of this mixture (containing 2000 cells) was then pipetted into each well of a 96-well concave-bottomed plate (Greiner Bio-One, Kremsmünster, Austria) and incubated at 37°C for 24 h, which led to the formation of spheroids (1 per well) of equal size (;100 mm in diameter).
Coculture of BeWo spheroids with Ishikawa monolayers
Stable Ishikawa cells expressing different forms of DG were cultured overnight at 37°C in 96-well flat-bottom plates to form monolayers. Spheroids were collected from individual wells into 15 ml tubes (approximately 30 spheroids per tube) and centrifuged at 800 rpm for 5 min. The methylcellulose culture medium mix was carefully aspirated out, and the spheroids were washed 3 times with 1 ml PBS and centrifuged as above after each wash. After the final centrifugation, the spheroids were suspended in 50 ml of BeWo cell culture medium. Ishikawa monolayers in 96-well plates were washed 3 times with PBS and replenished with culture medium (50 ml/well). Spheroid suspension (50 ml containing approximately 30 spheroids) was added to each well of Ishikawa monolayer and incubated for 2 h at 37°C. The exact number of spheroids present in each well was counted; the wells were gently washed 3 times with 200 ml PBS to remove any unattached spheroids, and replenished with 100 ml of culture medium. The attached spheroids in each well were counted and the attachment rate (attached/prewashing spheroids) was calculated. Each experiment was based on the average of 4 cocultured wells per cell type, and the final data were the mean value of 4 independent experiments.
Statistics
Data are expressed as means 6 SEM. Statistical analysis was performed on raw data; comparisons between 2 groups used Student's t test, multiple-group comparisons used 1-way ANOVA then Tukey's test (PRISM version 6.00, GraphPad Software, San Diego, CA, USA), with P , 0.05 taken as significant.
RESULTS
DG is initially synthesized as a single precursor protein and posttranslationally processed into 2 noncovalently associated a-DG and b-DG subunits (Fig. 1) . The 2 subunits are differentially localized in the cell, while b-DG is anchored across the plasma membrane with its C terminus localized inside and N terminus outside the cell (Fig. 1) , a-DG attaches through its C terminus to the extracellular N terminus of b-DG (Fig. 1) . Although b-DG lacks any well-defined structures, a-DG is dumbbell-shaped, containing 3 autonomous domains ( Fig. 1): an N-and a C-terminal globular domain, and an elongated mucinlike middle region that is highly decorated with N-and O-linked glycans through glycosylation (Fig. 1) . The central a-DG is reported to mediate cell adhesion through the glycans (40) , but this region is blocked by its bulky N terminus (a-DG-N), and a-DG-N removal is required for DG to function in cell adhesion. We bioinformatically identified a single PC6-cleavage site in a-DG at amino acid 312, precisely at the junction between a-DG-N and the central a-DG (Fig. 1) . Cleavage at this site would remove a-DG-N and expose the central region of a-DG to mediate cell adhesion. We aimed to experimentally prove that a-DG-N is removed by PC6 in the human endometrium in preparation for embryo implantation and that a-DG-N removal is critical for endometrial receptivity. 
Confirmation that PC6 cleaves a-DG in vitro
To confirm that PC6 can cleave a-DG as predicted, a 20 amino acid peptide harboring the predicted PC6-cleavage site in a-DG, ANKKPPLPKRVRR↓ 312 QIHATPTP (aa 299-319, designated as the WT peptide), was incubated with and without recombinant human PC6 in vitro, and the cleavage products were analyzed by SELDI mass spectrometry (Fig.  2A) . The parental peptide showed a mass to charge (m/z) ratio of 2447 ( Fig. 2A) . A 1602 m/z cleavage peptide was detected following incubation with PC6, consistent with a specific PC6 cleavage at the predicted site, but no cleavage product was seen in the absence of PC6 (Fig. 2A) . To further confirm the cleavage specificity, the amino acids around the cleavage site were replaced with alanines and the Mut peptide ANKKPPLPAA 312 AAAQIHATPT was similarly incubated with and without PC6 (Fig. 2B) . The Mut peptide was seen at 2107 m/z as expected, but PC6 failed to cleave the Mut peptide (Fig. 2B ).
PC6 releases a-DG-N from the plasma membrane in human endometrial epithelial cells
To further prove that PC6 is responsible for cleaving a-DG-N off for endometrial receptivity, we utilized a previously established stable PC6 knockdown HEC-1A cell model (2) . The PC6 knockdown (PC6-siRNA) cells contain ;50% less PC6 and are ;50% less adhesive to blastocyst attachment than the control cells (2) (Fig. 3A) . In the cell lysates, similar bands were detected between control and PC6-siRNA cells for the C (b-DG-C) and N termini (b-DG-N) of b-DG by antibodies 4F7 and N14, respectively, and the C terminus of a-DG (a-DG-C) by antibody C15 (Fig. 3B) . However, no bands were detected in either lysates for the N terminus of a-DG (a-DG-N) by antibody N18 (Fig. 3B) . On the other hand, the medium presented a different pattern; although no bands were detected for b-DG-C, b-DG-N, or a-DG-C in either cell type (Fig. 3B) , a clear band was detected for a-DG-N, and the levels were markedly reduced in PC6-siRNA compared with control cells (Fig. 3B) . These data indicated that the entire b-DG and the a-DG-C were within (or associated with) the cell, while a-DG-N was released into the medium, and that PC6 knockdown inhibited the release of a-DG-N without affecting any other parts of DG. To further confirm that PC6 knockdown caused a-DG-N retention on the plasma membrane, we prepared membrane proteins and examined for a-DG-N by Western blot (Fig. 3C) . A band (;90 kDa) was seen in PC6-siRNA but not in control cells, consistent with a-DG-N being retained in PC6-siRNA cells.
We next determined the cellular localization of b-DG and a-DG-N in control and PC6-siRNA cells by immunofluorescence (Fig. 4) . The b-DG protein was clearly localized on the cell membrane, and there was no difference between the 2 cell types (Fig. 4A, B) . In contrast, a-DG-N was detected much more clearly at the cell boundaries in PC6-siRNA than control cells (Fig. 4C, D) . This further confirmed that a-DG-N was cleaved off the cell membrane in control cells and that this cleavage was reduced in PC6-siRNA cells.
Cellular localization of DG subunits in the human endometrium
To validate that PC6 cleavage of a-DG-N is physiologically relevant in the human endometrium, we examined the localization of DG subunits across the menstrual cycle in women. Endometrial epithelial PC6 expression is low in the midproliferative (nonreceptive) phase and significantly increased in the midsecretory (receptive) phase (9) . Midsecretory epithelial cells would thus be expected to contain less a-DG-N in proportion to other DG components. The b-DG subunit was localized in both glandular and luminal epithelial cells in all tissues examined (Fig.  5A-D) , and the staining intensity was significantly elevated in the midsecretory compared with the midproliferative phase (Fig. 5M) . A very similar pattern of immunostaining was seen for a-DG-C in the glandular and luminal epithelium ( Fig. 5E-H) , and the levels were also significantly increased in the midsecretory phase (Fig. 5M) . In contrast, a-DG-N showed a different pattern. Although also being stained in the glandular and luminal epithelial cells (Fig.  5I-L) , a-DG-N intensity was not significantly different between the 2 phases (Fig. 5M) . The ratio of a-DG-N over a-DG-C was thus significantly reduced in the midsecretory phase (Fig. 5N) , consistent with a-DG-N being posttranslationally removed from the epithelial cells in the receptive phase.
Detection of a-DG-N in human uterine fluids
We next assessed whether the a-DG-N removed from the endometrial epithelial cells is detectable in uterine fluids from women and whether the levels differ between receptive and nonreceptive phases. Western blot analysis detected a-DG-N in all uterine lavage fluids collected from women (Fig. 6A) , and the levels were significantly higher in the secretory compared with proliferative phase (Fig. 6A, B) . These data suggest that more a-DG-N was released from the tissue into the uterine fluid in the secretory phase.
A single amino acid mutation at R 312 prevents a-DG-N removal from the cell membrane To further prove that PC6 is responsible for cleaving a-DG-N from the cell membrane, we engineered constructs Figure 5 . Immunolocalization of DG subunits in the human endometrium. A-L) Representative images of immunostaining in the glandular (GE) and luminal epithelium (LE) in the midproliferative (mid-prolif) and midsecretory (mid-sec) phases. A-D) b-DG, (E-H) a-DG-C, and (I-L) a-DG-N. Inserts are negative controls. Scale bar, 100 mm. M ) Mean intensity of glandular epithelial staining for b-DG, a-DG-C, and a-DG-N respectively. Each bar represents mean 6 SEM (n = 6 for each phase). *P , 0.05. N ) The ratio of a-DG-N/a-DG-C. ***P , 0.0005. specific transfection of WT DG and Mut DG. In the same lysates, b-DG was clearly increased in WT DG as well as Mut DG cells compared with the 2 controls (Fig. 7A) , confirming DG overexpression in both WT DG and Mut DG cells. DDK (tagged at the C terminus of b-DG) and b-DG were detected in the lysates but not in the conditioned media (Fig. 7A) , consistent with b-DG being membrane bound. Western blot for a-DG-N, however, showed a drastically different pattern between WT DG and Mut DG cells. A strong dominant band at ;37 kDa, consistent with the size of the cleaved a-DG-N, was detected in both the lysates and media of WT DG cells (Fig. 7A) . However, the Mut DG cells showed a dominant band at ;150 kDa (consistent with the size of intact a-DG) in the lysates but no bands in the media (Fig. 7A) . These data confirmed that the single site mutation at R 312 in the PC6-cleavage site prevented a-DG-N cleavage.
To further validate that Mut DG cells retained a-DG-N on the cell membrane, we determined the cellular localization of b-DG and a-DG-N in the above cells by immunofluorescence (Fig. 7B) . Membrane localization of b-DG was detected in all cells, and the levels were higher in WT DG and Mut DG cells than the 2 controls, consistent with b-DG overexpression in WT DG as well as in Mut DG cells. In contrast, high levels of a-DG-N were detected only in Mut DG cells, consistent with increased retention of a-DG-N on the cell membrane in these cells.
Intact DG inhibits cell adhesion
We next assessed whether preventing a-DG-N cleavage would affect cell adhesion. As DG, in particularly the central a-DG, is known to bind to laminin (31), we first examined the laminin adhesion of Ishikawa cells expressing different forms of DG (Fig. 8A) . As cells of nontransfection and control-transfection were very similar in adhesion (Fig. 8A) , confirming DG overexpression enhanced laminin binding. However, this increase in laminin binding was completely absent in cells expressing Mut DG, so that Mut DG-expressing cells were 3 times less adhesive than WT DG cells (Fig. 8A) . As the only difference between the 2 cell types is a-DG-N being cleaved in WT DG but retained on the cell membrane in Mut DG cells, these data provide compelling evidence that a-DG-N removal was critical for DG to bind to laminin and that intact DG inhibits the binding.
We next examined adhesion to fibronectin, a protein expressed by the blastocyst trophectoderm and widely used as a trophectodermal protein in in vitro adhesion assays (41) . The pattern of Ishikawa cell adhesion to fibronectin was essentially the same as that of laminin (Fig. 8A, B) . Again, Mut DG cells were significantly less adhesive than WT DG cells, suggesting that a-DG-N removal is likely important for endometrial epithelial cells to bind to blastocyst.
To further substantiate this proposition, we made equalsized BeWo trophoblast spheroids (;100 mm in diameter; Fig. 8C , top left panel) as surrogates of human blastocysts, and in parallel, cultured Ishikawa cells expressing different forms of DG to monolayers (Fig. 8C , top right panel) as a mimic of endometrial luminal epithelium. Equal numbers of trophoblast spheroids were then cocultured with different Ishikawa monolayers and spheroid attachment was assessed. WT DG-expressing cells were 1.5 times more adhesive to spheroids than the controls (Fig. 8C) , confirming DG overexpression enhanced Ishikawa cell receptivity to spheroid attachment. On the other hand, Mut DGexpressing cells were essentially the same as the controls and significantly less adhesive than WT DG cells (Fig. 8C) , demonstrating that intact DG in Ishikawa cells inhibited spheroid adhesion. Taken together, these data strongly suggest that intact DG in endometrial epithelial cells acts as a barrier for laminin binding, fibronectin adhesion, and trophoblast spheroid attachment.
DISCUSSION
Endometrial luminal epithelium is the first contact by a blastocyst to initiate implantation, but mechanisms governing endometrial epithelial receptivity in the human are poorly understood. This study demonstrated the importance of posttranslational modification of DG in the establishment of human endometrial receptivity. DG is known to mediate cell adhesion through the glycosylated central region of a-DG, but this region is obstructed by its large N terminus a-DG-N. Removal of a-DG-N to unmask the central a-DG is thus a key step in controlling the adhesive function of DG. In this study, we demonstrated that in the human endometrium, the full-length a-DG is a barrier for embryo attachment and that proteolytic removal of a-DG-N by PC6 (a protease critical for endometrial receptivity) regulates receptivity. We provided the following supporting evidence: 1) a-DG contains a PC6-cleavage site at the junction between a-DG-N and the central a-DG, and PC6 specifically cleaved a peptide harboring such a site; 2) knockdown of PC6 inhibited a-DG-N removal from endometrial epithelial cell surface and blastocyst adhesion; 3) mutating a single amino acid at the PC6-cleavage site prevented a-DG-N removal, causing cell surface retention of full-length a-DG and loss of adhesiveness; 4) a-DG-N was removed from endometrial tissue in vivo; this was significantly increased in the receptive phase when PC6 was high, and uterine fluid a-DG-N reflected tissue release and hence receptivity. We thus identified removal of a-DG-N as an important posttranslational control of endometrial receptivity, and uterine fluid a-DG-N as a potential biomarker for receptivity in women. Endometrial receptivity involves major morphologic changes to the surface of the endometrium, including the glycocalyx, which in general is believed to be a steric hindrance for blastocyst attachment and must be thinned/modified for receptivity. The mechanisms of glycocalyx thinning are understood relatively better in rodents than in humans. In mice, MUC-1, a large glycoprotein of the glycocalyx, is lowered on the endometrial epithelial surface in the receptive phase through gene down-regulation (42) ; this leads to a significant reduction in the thickness of the glycocalyx. However, in women, although MUC1 is lost locally at the site of embryo attachment in vitro (3), it is continuously present on the endometrial surface throughout the menstrual cycle in vivo, and the levels are increased rather than decreased in the window of implantation (3, 43) . It is thus speculated that in the human, posttranscriptional and/or posttranslational regulation governs the rapid alterations of cell surface composition for receptivity. Ultrastructural studies revealed marked cyclic changes of glycan presentation on the apical surface of the human endometrium, with some glycans actually increasing at receptivity (44) . For instance, certain glycans are up-regulated at receptivity to serve as oligosaccharide-based ligands for L-selectin on the blastocyst (45) . These studies suggest that the process of endometrial epithelial glycocalyx remodeling for receptivity in the human is complex, involving removal of certain anti-adhesive elements while unmasking certain adhesive glycans (46) . To date, the mechanisms of glycocalyx remodeling in the human endometrial epithelium for receptivity remain elusive (47) .
This current study highlighted the significance of posttranslational removal of a-DG-N by PC6 in the establishment of human endometrial receptivity. PCs function as "master switch" molecules to posttranslationally cleave precursor proteins into their active forms (48) , and PC6 is the only member that is tightly regulated in the endometrium for implantation (9) (10) (11) 13) . The critical importance of PC6 in endometrial receptivity was evidenced in a unique PC6-knockdown HEC-1A cell model in which PC6 reduction significantly reduced receptivity to blastocyst attachment (2) . Using this cell model, we now revealed that PC6 knockdown inhibited the removal of a-DG-N without affecting any other components of glycoprotein DG. In the human endometrium, a-DG-N removal is significantly increased in the midsecretory phase (12) , coinciding with PC6 upregulation and receptivity. These results strongly suggest that PC6 plays a key role in removing a-DG-N from the plasma membrane to facilitate the adhesive function of DG for receptivity
To further prove the above notion, we transfected Ishikawa cells with different DG constructs. Cells expressing the WT DG were significantly more adhesive than the controls to extracellular proteins laminin and fibronectin, as well as to human trophoblast spheroids; this demonstrated that DG facilitates adhesion. However, this gain of adhesion by DG transfection was completely abolished by mutating R 312 in DG at the PC6-cleavage site. A single amino acid mutation prevented removal of a-DG-N from the cell surface; cells expressing the Mut DG retained the full-length a-DG and were significantly less adhesive than WT DG cells. These data provided compelling evidence that the full-length a-DG is a barrier and that PC6-mediated a-DG-N removal controls the adhesive function of DG in human endometrial epithelial cells.
Furthermore, the a-DG-N removed from the endometrial tissue in vivo was present in the uterine fluid, and uterine fluid a-DG-N levels reflected tissue removal of a-DG-N and endometrial receptivity. Therefore, a-DG-N in the uterine fluid may provide a much needed nontissue biomarker for receptivity assessment.
In summary, we have demonstrated that the intact a-DG in human endometrial epithelial cells is a barrier for embryo attachment and that a-DG-N removal is an important posttranslational control of receptivity. We have further revealed that a-DG-N removal is exerted by protease PC6 and that uterine fluid a-DG-N is a potential biomarker for noninvasive determination of endometrial receptivity. All data were normalized to control and are expressed as means 6 SEM of 4 independent experiments. *P , 0.05, **P , 0.005, ***P , 0.0005, ****P , 0.0001. 
